Literature DB >> 28687661

A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine.

Jue Hou1, Shuhui Wang1, Manxue Jia1, Dan Li1, Ying Liu1, Zhengpeng Li1, Hong Zhu2, Huifang Xu2, Meiping Sun3, Li Lu3, Zhinan Zhou3, Hong Peng1, Qichen Zhang1, Shihong Fu4,5, Guodong Liang4,5, Lena Yao6, Xuesong Yu6, Lindsay N Carpp6, Yunda Huang6, Julie McElrath6, Steve Self6, Yiming Shao7,8.   

Abstract

In this study, we used a systems vaccinology approach to identify temporal changes in immune response signatures to the yellow fever (YF)-17D vaccine, with the aim of comprehensively characterizing immune responses associated with protective immunity. We conducted a cohort study in which 21 healthy subjects in China were administered one dose of the YF-17D vaccine; PBMCs were collected at 0 h and then at 4 h and days 1, 2, 3, 5, 7, 14, 28, 84, and 168 postvaccination, and analyzed by transcriptional profiling and immunological assays. At 4 h postvaccination, genes associated with innate cell differentiation and cytokine pathways were dramatically downregulated, whereas receptor genes were upregulated, compared with their baseline levels at 0 h. Immune response pathways were primarily upregulated on days 5 and 7, accompanied by the upregulation of the transcriptional factors JUP, STAT1, and EIF2AK2. We also observed robust activation of innate immunity within 2 d postvaccination and a durable adaptive response, as assessed by transcriptional profiling. Coexpression network analysis indicated that lysosome activity and lymphocyte proliferation were associated with dendritic cell (DC) and CD4+ T cell responses; FGL2, NFAM1, CCR1, and TNFSF13B were involved in these associations. Moreover, individuals who were baseline-seropositive for Abs against another flavivirus exhibited significantly impaired DC, NK cell, and T cell function in response to YF-17D vaccination. Overall, our findings indicate that YF-17D vaccination induces a prompt innate immune response and DC activation, a robust Ag-specific T cell response, and a persistent B cell/memory B cell response.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28687661      PMCID: PMC6681914          DOI: 10.4049/jimmunol.1700083

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  64 in total

1.  The yellow fever 17D vaccine virus as a vector for the expression of foreign proteins: development of new live flavivirus vaccines.

Authors:  M C Bonaldo; P S Caufour; M S Freire; R Galler
Journal:  Mem Inst Oswaldo Cruz       Date:  2000       Impact factor: 2.743

Review 2.  Evasion of innate and adaptive immunity by flaviviruses.

Authors:  Michael S Diamond
Journal:  Immunol Cell Biol       Date:  2003-06       Impact factor: 5.126

3.  Medicine. The need for a global HIV vaccine enterprise.

Authors:  Richard D Klausner; Anthony S Fauci; Lawrence Corey; Gary J Nabel; Helene Gayle; Seth Berkley; Barton F Haynes; David Baltimore; Chris Collins; R Gordon Douglas; Jose Esparza; Donald P Francis; N K Ganguly; Julie Louise Gerberding; Margaret I Johnston; Michel D Kazatchkine; Andrew J McMichael; Malegapuru W Makgoba; Giuseppe Pantaleo; Peter Piot; Yiming Shao; Edmund Tramont; Harold Varmus; Judith N Wasserheit
Journal:  Science       Date:  2003-06-27       Impact factor: 47.728

4.  B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1.

Authors:  H B Shu; H Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 5.  The mechanisms of action of PPARs.

Authors:  Joel Berger; David E Moller
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

6.  Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis.

Authors:  Robert B Tesh; Amelia P A Travassos da Rosa; Hilda Guzman; Tais P Araujo; Shu-Yuan Xiao
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

7.  Ligand-receptor binding revealed by the TNF family member TALL-1.

Authors:  Yingfang Liu; Xia Hong; John Kappler; Ling Jiang; Rongguang Zhang; Liangguo Xu; Cheol-Ho Pan; Wesley E Martin; Robert C Murphy; Hong-Bing Shu; Shaodong Dai; Gongyi Zhang
Journal:  Nature       Date:  2003-05-01       Impact factor: 49.962

8.  NFAM1, an immunoreceptor tyrosine-based activation motif-bearing molecule that regulates B cell development and signaling.

Authors:  Makoto Ohtsuka; Hisashi Arase; Arata Takeuchi; Sho Yamasaki; Ritsuko Shiina; Tadahiro Suenaga; Daiju Sakurai; Tadashi Yokosuka; Noriko Arase; Makio Iwashima; Toshio Kitamura; Hideshige Moriya; Takashi Saito
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-13       Impact factor: 11.205

Review 9.  The main function of IL-2 is to promote the development of T regulatory cells.

Authors:  Thomas R Malek
Journal:  J Leukoc Biol       Date:  2003-09-02       Impact factor: 4.962

Review 10.  BAFF: a fundamental survival factor for B cells.

Authors:  Fabienne Mackay; Jeffrey L Browning
Journal:  Nat Rev Immunol       Date:  2002-07       Impact factor: 53.106

View more
  16 in total

1.  Early molecular correlates of adverse events following yellow fever vaccination.

Authors:  Candice Yy Chan; Kuan Rong Chan; Camillus Jh Chua; Sharifah Nur Hazirah; Sujoy Ghosh; Eng Eong Ooi; Jenny G Low
Journal:  JCI Insight       Date:  2017-10-05

2.  Vaccine-induced time- and age-dependent mucosal immunity to gastrointestinal parasite infection.

Authors:  Wei Liu; Tom N McNeilly; Mairi Mitchell; Stewart T G Burgess; Alasdair J Nisbet; Jacqueline B Matthews; Simon A Babayan
Journal:  NPJ Vaccines       Date:  2022-07-07       Impact factor: 9.399

3.  The Immune Signatures data resource, a compendium of systems vaccinology datasets.

Authors:  Joann Diray-Arce; Helen E R Miller; Evan Henrich; Steven H Kleinstein; Mayte Suárez-Fariñas; Bram Gerritsen; Matthew P Mulè; Slim Fourati; Jeremy Gygi; Thomas Hagan; Lewis Tomalin; Dmitry Rychkov; Dmitri Kazmin; Daniel G Chawla; Hailong Meng; Patrick Dunn; John Campbell; Minnie Sarwal; John S Tsang; Ofer Levy; Bali Pulendran; Rafick Sekaly; Aris Floratos; Raphael Gottardo
Journal:  Sci Data       Date:  2022-10-20       Impact factor: 8.501

Review 4.  Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe.

Authors:  Florian Douam; Alexander Ploss
Journal:  Trends Microbiol       Date:  2018-06-19       Impact factor: 17.079

Review 5.  Transcriptomics in Human Challenge Models.

Authors:  Amber J Barton; Jennifer Hill; Andrew J Pollard; Christoph J Blohmke
Journal:  Front Immunol       Date:  2017-12-18       Impact factor: 7.561

6.  A systematic approach to the development of a safe live attenuated Zika vaccine.

Authors:  Swee Sen Kwek; Satoru Watanabe; Kuan Rong Chan; Eugenia Z Ong; Hwee Cheng Tan; Wy Ching Ng; Mien T X Nguyen; Esther S Gan; Summer L Zhang; Kitti W K Chan; Jun Hao Tan; October M Sessions; Menchie Manuel; Julien Pompon; Camillus Chua; Sharifah Hazirah; Karl Tryggvason; Subhash G Vasudevan; Eng Eong Ooi
Journal:  Nat Commun       Date:  2018-03-12       Impact factor: 14.919

7.  Age-Related Changes in the Natural Killer Cell Response to Seasonal Influenza Vaccination Are Not Influenced by a Synbiotic: a Randomised Controlled Trial.

Authors:  Agnieszka Przemska-Kosicka; Caroline E Childs; Catherine Maidens; Honglin Dong; Susan Todd; Margot A Gosney; Kieran Michael Tuohy; Parveen Yaqoob
Journal:  Front Immunol       Date:  2018-03-22       Impact factor: 7.561

8.  Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in Humans.

Authors:  Jenna Anderson; Thorunn A Olafsdottir; Sven Kratochvil; Paul F McKay; Malin Östensson; Josefine Persson; Robin J Shattock; Ali M Harandi
Journal:  Front Immunol       Date:  2018-02-26       Impact factor: 7.561

9.  Systems Immunology Characterization of Novel Vaccine Formulations for Mycoplasma hyopneumoniae Bacterins.

Authors:  Anneleen M F Matthijs; Gaël Auray; Virginie Jakob; Obdulio García-Nicolás; Roman O Braun; Irene Keller; Rémy Bruggman; Bert Devriendt; Filip Boyen; Carlos A Guzman; Annelies Michiels; Freddy Haesebrouck; Nicolas Collin; Christophe Barnier-Quer; Dominiek Maes; Artur Summerfield
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

Review 10.  Predictive Markers of Immunogenicity and Efficacy for Human Vaccines.

Authors:  Matthieu Van Tilbeurgh; Katia Lemdani; Anne-Sophie Beignon; Catherine Chapon; Nicolas Tchitchek; Lina Cheraitia; Ernesto Marcos Lopez; Quentin Pascal; Roger Le Grand; Pauline Maisonnasse; Caroline Manet
Journal:  Vaccines (Basel)       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.